Plain-English translation of NCT06958666 on ClinicalTrials.gov โ ยท
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing two treatments โ digital inhaler management (a smartphone-connected device that reminds you to use your inhaler and gives you feedback) and inspiratory muscle training (exercises to strengthen your breathing muscles) โ to see if they can help people with severe COPD have fewer dangerous flare-ups and stay out of the hospital. You'll be in one of four groups: one getting the digital device alone, one doing breathing exercises alone, one getting both treatments, or one getting standard care only.
People with severe COPD often have flare-ups that land them in the hospital, and their symptoms can make daily life very difficult. This study wants to find out whether better inhaler use (with digital help) and stronger breathing muscles can prevent these serious flare-ups and improve quality of life.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You'll attend study visits at the start, then at 3 months, 6 months, and 12 months. Depending on which group you're in, you may receive training on using a digital inhaler device with a smartphone app that sends you reminders, practice breathing exercises using special equipment, or receive standard inhaler technique training. You'll complete questionnaires about your symptoms and quality of life, and have lung function tests to measure how well your lungs are working.
AI-generated summary from trial data ยท Jun 29, 2026 ยท Not medical advice
China